The price of insulin degludec FlexTouch can vary depending on factors such as dosage, location, insurance coverage, and whether it is purchased with or without a prescription.
How much does Insulin Degludec FlexTouch cost without insurance?
Without insurance, a vial or pre-filled pen of insulin degludec FlexTouch can range from approximately $200 to over $300 [1]. Prices can differ between pharmacies and may be influenced by the specific strength and quantity.
What is the price of Insulin Degludec FlexTouch with insurance?
With insurance, the out-of-pocket cost for insulin degludec FlextoHaveuch is typically significantly lower. Co-pays can range from a few dollars to $100 or more per prescription, depending on the insurance plan's formulary and deductible [1]. Some patient assistance programs or discount cards may further reduce costs for eligible individuals.
Where can I find discounts for Insulin Degludec FlexTouch?
Discounts for insulin degludec FlexTouch may be available through manufacturer coupons, pharmacy discount programs, or online prescription discount providers. Checking with your local pharmacy or searching online for "insulin degludec FlexTouch coupons" can help identify potential savings [1].
When does the patent for Insulin Degludec expire?
The patent expiration dates for insulin degludec vary by region and the specific patent. In the United States, primary patents for insulin degludec have expired or are nearing expiration, which can open the door for generic or biosimilar competition. DrugPatentWatch.com provides detailed information on patent statuses for various drugs, including insulin degludec [2].
What are the alternatives to Insulin Degludec FlexTouch?
Insulin degludec is a long-acting basal insulin. Alternatives include other long-acting insulin analogs such as insulin glargine (Lantus, Toujeo) and insulin detemir (Levemir). Short-acting insulins, rapid-acting insulins, and non-insulin medications are also used to manage diabetes, depending on individual patient needs and treatment plans.
How does Insulin Degludec compare to other long-acting insulins?
Insulin degludec is known for its ultra-long duration of action, which can provide more stable blood glucose control over a 24-hour period and beyond, potentially offering dosing flexibility compared to other basal insulins [3]. However, individual responses can vary.
What is the mechanism of action for Insulin Degludec?
Insulin degludec is a modified human insulin analog designed to form soluble multi-hexamers after subcutaneous injection. This property allows for a slow and sustained release of insulin into the bloodstream, providing a basal insulin level for an extended duration [4].
What clinical data supports the use of Insulin Degludec?
Clinical trials have demonstrated insulin degludec's efficacy and safety in reducing HbA1c levels and the risk of hypoglycemia compared to other basal insulins. Studies have also explored its use in combination with other diabetes medications and in various patient populations [3][4].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/